Literature DB >> 12353860

Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease.

Nobuhide Oshitani1, Fumihiko Hato, Yoshio Jinno, Yoshinori Sawa, Junichi Hara, Shiro Nakamura, Takayuki Matsumoto, Tetsuo Arakawa, Atsuo Kitano, Seiichi Kitagawa, Tetsuo Kuroki.   

Abstract

Studies of the T-cell-receptor repertoire and oligoclonal expansion of lamina propria T cells in patients with Crohn's disease suggest restricted antigen processing in this disease. We examined HPLC elution profiles of HLA-DR-bound peptides isolated from human intestine. Surgical samples of colon and ileum were obtained from patients with ulcerative colitis, patients with Crohn's disease, and normal colon from patients undergoing colon carcinoma treatment as controls. Specimens were homogenized and HLA-DR molecules were isolated using anti-HLA-DR antibody-coupled immunoaffinity chromatography. HLA-DR-bound peptides were dissociated from the HLA-DR groove by acid treatment, isolated, and analyzed by reversed-phase HPLC. HPLC elution profiles of HLA-DR-bound peptides were similar in patients with ulcerative colitis and controls. Large peaks were found in patients with Crohn's disease, but the retention times of these peaks differed among individuals. Elution profiles of HLA-DR bound peptides suggest that specific antigen presentation might occur in patients with Crohn's disease, although the specific antigens appear to differ between patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353860     DOI: 10.1023/a:1019689332601

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

Authors:  D F Hunt; H Michel; T A Dickinson; J Shabanowitz; A L Cox; K Sakaguchi; E Appella; H M Grey; A Sette
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

2.  Sequence analysis of peptides bound to MHC class II molecules.

Authors:  A Rudensky; P Preston-Hurlburt; S C Hong; A Barlow; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

3.  Universal skew of T cell receptor (TCR) V beta usage for Crohn's disease (CrD).

Authors:  H Ogawa; H Ito; A Takeda; S Kanazawa; M Yamamoto; H Nakamura; Y Kimura; K Yoshizaki; T Kishimoto
Journal:  Biochem Biophys Res Commun       Date:  1997-11-26       Impact factor: 3.575

Review 4.  Antigen presentation.

Authors:  E R Unanue; J C Cerottini
Journal:  FASEB J       Date:  1989-11       Impact factor: 5.191

5.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

6.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.

Authors:  T Hibi; M Ohara; M Watanabe; T Kanai; H Takaishi; A Hayashi; Y Hosoda; H Ogata; Y Iwao; S Aiso
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

8.  Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

Authors:  B Gulwani-Akolkar; P N Akolkar; A Minassian; R Pergolizzi; M McKinley; G Mullin; S Fisher; J Silver
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

9.  Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

Authors:  W S Selby; L W Poulter; S Hobbs; D P Jewell; G Janossy
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

10.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.